drugset / Trial / NCT06368440

A Study to Investigate the Safety and Pharmacokinetics of AZD6793 in Healthy Japanese and Chinese Participants

NCT06368440 ↗

Phase 1 Completed 39 enrolled AstraZeneca
RandomizedSequentialTriple-blindOther

Summary

The main purpose of this study is to assess the safety, tolerability and pharmacokinetics (PK) of oral AZD6793 in healthy Japanese and Chinese participants.

Timeline

Start
2024-05-15
Primary completion
2024-12-23
Completion
2024-12-23

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD6793 Unknown — Oral

Indications

No indication recorded.